NEXGEL Appoints Joseph McGuire To Succeed Adam Drapczuk III As CFO

(RTTNews) - NEXGEL, Inc. (NXGL), a provider of medical and over-the-counter (OTC) products, announced Thursday the appointment of Joseph McGuire as Chief Financial Officer, effective January 1, 2025. Adam Drapczuk III, current Chief Financial Officer, will remain with the Company as a consultant as he builds his own consulting business through Achieving Consulting Excellence, LLC.

McGuire has over 30 years of financial and public company experience, having served as CFO for several privately held and publicly traded companies in the health care, financial services, investment, and manufacturing industries.

He was a key member of the team that successfully guided a biotechnology company through its IPO, resulting in its listing on the NYSE in July 2022. He began his career with Price Waterhouse, where he was a certified public accountant, and later held management positions with Dean Witter Reynolds and Paine Webber, Inc.

McGuire has consulted with NEXGEL since September 2, 2024, and will serve on the executive management team to lead the Company's finance functions.